| Literature DB >> 23190550 |
Hanqiao Liang1, Yongmei Xing, Juan Chen, Dawei Zhang, Shunxing Guo, Chunlan Wang.
Abstract
BACKGROUND: Drug resistance in bacteria has become a global concern and the search for new antibacterial agents is urgent and ongoing. Endophytes provide an abundant reservoir of bioactive metabolites for medicinal exploitation, and an increasing number of novel compounds are being isolated from endophytic fungi. Ophiopogon japonicus, containing compounds with antibacterial activity, is a traditional Chinese medicinal plant used for eliminating phlegm, relieving coughs, latent heat in the lungs, and alleviating diabetes mellitus. We investigated the antimicrobial activities of 30 strains of O. japonicus.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23190550 PMCID: PMC3534486 DOI: 10.1186/1472-6882-12-238
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Figure 1Neighbour-joining (NJ) phylogenetic tree based on ITS-rDNA sequences of endophytic fungi associated with the . Numbers above or below branches indicate bootstrap values of NJ and MP analyses (> 50%, right) from 1000 bootstrap replicates.
Figure 2Light micrographs of endophytic fungi isolated from . a and bFusarium isolated from stem and root of O. japonicus. cAspergillus isolated from root of O. japonicus. dCylindrocarpon isolated from root of O. japonicus.
Antimicrobial activities and culture time of endophytic fungi isolated from
| | | | | | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MD-01 | Root | — | — | + | — | — | — | — | — | 4 |
| MD-02 | Root | ++ | — | + | — | — | — | — | + | 4 |
| MD-03 | Root | — | — | +++ | — | — | — | + | — | 14 |
| MD-04 | Root | ++ | — | ++ | ++ | — | — | — | — | 11 |
| MD-05 | Root | + | — | — | + | — | — | — | — | 9 |
| MD-06 | Root | — | ++ | + | — | — | — | + | — | 10 |
| MD-07 | Root | — | — | + | + | — | — | — | — | 6 |
| MD-08 | Root | ++ | — | ++ | + | — | — | — | — | 15 |
| MD-09 | Root | +++ | — | +++ | +++ | — | — | + | +++ | 14 |
| MD-10 | Root | +++ | — | — | + | — | — | + | — | 9 |
| MD-11 | Root | ++ | — | — | — | — | — | — | + | 9 |
| MD-12 | Root | +++ | — | — | — | — | — | ++ | ++ | 5 |
| MD-13 | Root | +++ | — | + | — | — | — | — | — | 6 |
| MD-14 | Root | — | — | + | — | — | — | + | — | 10 |
| MD-15 | Root | — | — | +++ | — | — | — | ++ | — | 5 |
| MD-16 | Root | — | — | ++ | — | — | — | + | + | 5 |
| MD-17 | Root | — | — | — | — | — | — | + | — | 10 |
| MD-18 | Root | ++ | — | + | — | — | — | ++ | — | 10 |
| MD-19 | Root | — | — | ++ | — | — | — | ++ | + | 6 |
| MD-20 | Root | — | — | + | — | — | — | + | — | 16 |
| MD-21 | Stem | + | + | + | — | — | — | ++ | — | 6 |
| MD-22 | Stem | — | ++ | + | — | — | — | + | — | 5 |
| MD-23 | Stem | — | + | + | — | — | — | ++ | — | 4 |
| MD-24 | Stem | + | ++ | ++ | ++ | — | — | + | ++ | 14 |
| MD-25 | Stem | — | ++ | + | — | — | — | ++ | + | 4 |
| MD-26 | Stem | ++ | + | + | ++ | — | — | + | + | 14 |
| MD-27 | Stem | — | +++ | + | — | — | — | ++ | — | 4 |
| MD-28 | Stem | + | +++ | — | — | — | — | + | + | 4 |
| MD-29 | Root | ++ | — | ++ | +++ | — | — | — | ++ | 10 |
| MD-30 | Root | + | ++ | ++ | +++ | — | — | + | + | 10 |
The peptide deformylase inhibition and antimicrobial activities are expressed by the inhibition rate (IR): -, inhibition rate <30%; +, 30% ≤ inhibition rate <60; ++, 60% ≤ inhibition rate <90%; +++, 90 ≤ inhibition rate.